IBSSX
Price
$16.90
Change
-$0.17 (-1.00%)
Updated
Oct 7 closing price
Net Assets
325.93M
PEMGX
Price
$44.59
Change
-$0.32 (-0.71%)
Updated
Oct 7 closing price
Net Assets
33.08B
Interact to see
Advertisement

IBSSX vs PEMGX

Header iconIBSSX vs PEMGX Comparison
Open Charts IBSSX vs PEMGXBanner chart's image
VY® Baron Growth S
Price$16.90
Change-$0.17 (-1.00%)
VolumeN/A
Net Assets325.93M
Principal MidCap A
Price$44.59
Change-$0.32 (-0.71%)
VolumeN/A
Net Assets33.08B
IBSSX vs PEMGX Comparison Chart in %
View a ticker or compare two or three
VS
IBSSX vs. PEMGX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBSSX is a Hold and PEMGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 33.1B vs. IBSSX (326M). IBSSX pays higher dividends than PEMGX: IBSSX (0.28) vs PEMGX (0.00). IBSSX was incepted earlier than PEMGX: IBSSX (23 years) vs PEMGX (20 years). IBSSX (1.37) is less costly to investors than PEMGX (0.91). PEMGX is a more actively managed with annual turnover of: 10.50 vs. IBSSX (4.00). IBSSX has a lower initial minimum investment than PEMGX: IBSSX (0) vs PEMGX (1000). PEMGX annual gain was more profitable for investors over the last year : 4.13 vs. IBSSX (-27.56). PEMGX return over 5 years is better than : 39.26 vs. IBSSX (-30.42).
IBSSXPEMGXIBSSX / PEMGX
Total Expense Ratio1.250.91137%
Annual Report Gross Expense Ratio1.370.91151%
Fund Existence23 years20 years-
Gain YTD-27.2845.373-508%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets326M33.1B1%
Annual Yield % from dividends0.280.00-
Returns for 1 year-27.564.13-668%
Returns for 3 years-15.6854.12-29%
Returns for 5 years-30.4239.26-77%
Returns for 10 years-38.88105.92-37%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLIDX15.65N/A
N/A
Harding Loevner Intl Dev Mkts Eq Inst
FPHAX28.62N/A
N/A
Fidelity Select Pharmaceuticals Port
UTMAX12.03N/A
N/A
Victory Target Managed Allocation
GSILX21.81N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps C
DLCZX12.27-0.06
-0.49%
Destinations Large Cap Equity Z